Report Highlights
The global Preimplantation Genetic Testing Market was valued at USD 306.16 million in 2016 and is projected to reach USD 701.49 million by 2025, growing at a CAGR of 9.65% from 2017 to 2025.
Pre-implantation genetic diagnosis refers to the genetic profiling of embryos prior to implantation, and sometimes even of oocytes prior to fertilization. PGD is considered a necessary procedure because of rising cases of genetically imbalanced make up found in children and new born. The Government has stringent rules which affect the market significantly.
Market Dynamics:
1. Market Drivers
1.1 Increasing infertility issues
1.2 Increased fund in preimplantation consultation and testing
1.3 Growing demand of fertility clinics
1.4 Technological advancements in the preimplantation testing techniques
1.5 High chances of chromosomal abnormalities and awareness regarding the prevalence of genetic disorders
2. Market Restraints
2.1 Governmental regulations
2.2 High cost of testing
Market Segmentation:
1. Global Preimplantation Genetic Testing Market, by Technology:
1.1 Next-Generation Sequencing
1.2 Polymerase Chain Reaction
1.3 Fluorescence in Situ Hybridization
1.4 Comparative Genomic Hybridization
1.5 Single-Nucleotide Polymorphism
2. Global Preimplantation Genetic Testing Market, by Procedure Type:
2.1 Preimplantation Genetic Screening
2.2 Preimplantation Genetic Diagnosis
3. Global Preimplantation Genetic Testing Market, by Application:
3.1 Aneuploidy
3.2 Structural Chromosomal Abnormalities
3.2.1 Translocations
3.2.2 Deletions
3.2.3 Duplications
3.2.4 Inversions
3.3 Single Gene Disorders
3.4 X-Linked Disorders
3.5 HLA Typing
3.6 Gender Identification
4. Global Preimplantation Genetic Testing Market, by Products and Services:
4.1 Reagents and Consumables
4.2 Instruments
4.3 Software and Services
5. Global Preimplantation Genetic Testing Market, by End User:
5.1 Maternity Centers & Fertility Clinics
5.2 Hospitals, Diagnostic Labs, and Service Providers
5.3 Research Laboratories & Academic Institutes
6. Global Preimplantation Genetic Testing Market, by Region:
6.1 North America (U.S., Canada, Mexico)
6.2 Europe (Germany, UK, France, Rest of Europe)
6.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
6.4 Latin America (Brazil, Argentina, Rest of Latin America)
6.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Illumina, Inc.
2. Thermo Fisher Scientific Inc.
3. Agilent Technologies, Inc.
4. Perkinelmer, Inc.
5. Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)
6. ABBott Laboratories
7. Natera, Inc.
8. Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)
9. Oxford Gene Technology
10. Yikon Genomics
11. Scigene
12. Beijing Genomics Institute
13. Good Start Genetics, Inc.
14. Invicta Genetics
15. Combimatrix Corporation
16. Genea Limited
17. Progenesis
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Preimplantation Genetic Testing Marketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More